Command Palette

Search for a command to run...

The world's most comprehensive cannabis strain directory, backed by scientific research.

11,121 strains · 12,304 studies · 268 breeders

From a Designer Drug to the Discovery of Selective Cannabino — 2021 Review/Other | BudProfiles

PositiveReview/Other2021

From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis

AI Classification

Positive

Fine-tuned Classification

Positive

Negative

A Case of Panic Attacks Developing After 10 Years of Chronic Cannabis Use in a Patient With No Prior Psychiatric History

2023·Review/Other

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis

Cannabinoids for the Treatment of Dermatologic Conditions

Molecular Mechanisms for the Inflammation-Resolving Actions of Lenabasum

Cannabis and the skin

Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis

Synthetic Cannabinoid (unspecified)

Integumentary System